HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vasileios J Assikis Selected Research

Prostatic Neoplasms (Prostate Cancer)

10/2011Phase II randomized, double-blind, placebo-controlled study of tasquinimod in men with minimally symptomatic metastatic castrate-resistant prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Vasileios J Assikis Research Topics

Disease

1Fatigue
10/2011
1Pain (Aches)
10/2011
1Prostatic Neoplasms (Prostate Cancer)
10/2011
1Disease Progression
10/2011
1Musculoskeletal Pain
10/2011

Drug/Important Bio-Agent (IBA)

1tasquinimodIBA
10/2011
1Antineoplastic Agents (Antineoplastics)IBA
10/2011
1Biomarkers (Surrogate Marker)IBA
10/2011
1Prostate-Specific Antigen (Semenogelase)IBA
10/2011

Therapy/Procedure

1Castration
10/2011